Respiratory

Extreme heat was linked to higher asthma emergency department visits among adults and children in Baltimore, especially after hot nights.

Gabapentinoids were linked to higher asthma exacerbation risk among adults with asthma and chronic or neuropathic pain.

Maternal RSV vaccination was linked to lower infant hospitalization as uptake gaps persisted across Dallas mothers.

New pulmonary embolism guidance introduces sharper clinical categories to improve diagnosis, treatment, and follow-up care.

Asthma treatment strategies are shifting as new clinical trial data highlight the benefits of anti-inflammatory reliever approaches over traditional bronchodilator-only therapies.

Pulmonary nodule evaluation on CT scans may be significantly enhanced through artificial intelligence, as a transformer-based model demonstrates strong diagnostic performance and clinical utility in a multi-reader, multi-case trial.

Respiratory viral infections may increase lung cancer risk and accelerate tumor growth through lasting immune changes.

Breastfeeding for at least four months was linked to lower asthma and IgE sensitization into young adulthood.

Higher alcohol consumption is linked to increased risk of early small airway obstruction in adults.

COPD in never-smokers showed more symptoms and type 2 inflammation, pointing to a distinct clinical phenotype.

Bronchiectasis may silently increase risk of non-tuberculous mycobacteria infection, according to new genetic evidence.

A new review of respiratory mechanics modeling highlights how advanced measurement techniques could improve the diagnosis and monitoring of respiratory diseases including asthma and COPD.

A new registry study reveals human metapneumovirus causes severe illness in blood cancer patients worldwide.

Mycoplasma pneumoniae infection in children may lead to plastic bronchitis, with new predictors aiding early detection.

Hospital-acquired pneumonia remains a lethal ICU threat, but its diagnosis and management are entering a more precise era.

Severe childhood asthma continues to cause major morbidity in low- and middle-income countries despite its low prevalence.

Nirsevimab was linked to fewer RSV hospitalizations and severe neonatal outcomes than maternal RSVpreF vaccination in France.

A nationwide cohort study found high in-hospital mortality among adults receiving ECMO, with risk shaped by age and comorbidity

Obstructive sleep apnea affected nearly half of never-smokers with newly diagnosed lung cancer in this prospective study.

Osteopathic manipulative treatment may offer a new way to support pulmonary function in asthma. Read more.

COPD breathlessness action plans may help patients manage episodes, reduce anxiety, and avoid emergency care. Read more.

Obstructive sleep apnea syndrome may be linked to oxidative stress, according to a Mendelian randomization study.

Idiopathic pulmonary fibrosis progression may begin nearly a decade before symptoms, according to new modeling research.

Nerandomilast reduced lung inflammation and fibrosis in IIM-ILD preclinical models. Read more to find out what this means for the future.

STEM cell therapy is emerging as a promising approach for silicosis, an irreversible fibrotic lung disease caused by chronic exposure to respirable crystalline silica.

Higher cardiorespiratory fitness linked to lower COVID-19 hospitalization risk, but not SARS-CoV-2 infection, in a large population cohort.

Obesity hypoventilation syndrome treatment improved as acetazolamide with atomoxetine reduced mean CO2 and AHI, raising saturation.

A mouse long COVID model associates breathlessness with postinfectious fibrotic lung remodeling and neuroinflammation following clearance.

Statewide Texas survey data link indoor ventilation and smoking to higher adult asthma morbidity from 2019–2022.

Sleep apnea specific hypoxic burden predicted higher 30-day postoperative mortality and cardiac complications after major surgery.

A mobile instant messaging exercise-program did not significantly improve lab-verified smoking-cessation overall rates at 6 months.

Pediatric obstructive sleep apnea raised influenza and COVID-19 diagnoses over five years in a U.S. TriNetX large EHR cohort study.

Children with cystic fibrosis showed lower short chain fatty acids, associated with dietary patterns and inflammation.

Smoking and quitting behaviors in England 2014 to 2023 show clear socioeconomic disadvantage tied to smoking and addiction overall.

A CureTB analysis found: 79% treatment completion after international relocation, with timelier linkage improving outcomes overall.

Retrospective signals have suggested that treatment timing may influence immunochemotherapy efficacy, but prospective evidence has been limited.

Stopping LAMA or ICS in COPD, raised exacerbation risk for three months, with pronounced withdrawal-associated spikes.

Circulating microRNAs shifted during OGTT, distinguishing cystic fibrosis-related diabetes from earlier intolerance in CF cohorts.

GLP-1 receptor agonists were associated with increased incident chronic cough among adults with type 2 diabetes, in US EHR records.

In advanced NSCLC, progression by new lesions predicted shorter post-progression survival following first-line therapy.

Salt intake advice in cystic fibrosis is under review after ETI improved conservation and blood pressure.

Major depressive disorder predicted long-term asthma outcomes in adults 60+ with beliefs mediating control QoL, and steroid bursts.

Telemedicine in bronchial asthma improved asthma control, especially using telemonitoring, education, or combined support programs.

In idiopathic pulmonary fibrosis, ACE inhibitor use was associated with lower all-cause mortality in propensity matched EHR cohorts.

Pulmonary siderosis in one metalworker can resemble pneumoconiosis and may represent clinically significant systemic iron overload.

In idiopathic pulmonary fibrosis, ACE inhibitor therapy correlated with reduced all-cause mortality in matched records unlike COPD.

Chronic lung disease and socioeconomic disadvantage were tied to markedly increased lung cancer risk, among never-smokers in Korea.

US cost-effectiveness analysis showed durvalumab in limited-stage small cell lung cancer improved survival but exceeded thresholds.